Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3863 Neoplasms 2988 Prostatic Neoplasms 1754 Colorectal Neoplasms 1430 Lung Neoplasms 1331 Motor Activity 805 Head and Neck Neoplasms 686 Pancreatic Neoplasms 663 Colonic Neoplasms 655 Uterine Cervical Neoplasms 653 Carcinoma, Non-Small-Cell Lung 631 Carcinoma, Hepatocellular 631 Rectal Neoplasms 571 Stomach Neoplasms 547 Brain Neoplasms 484 Ovarian Neoplasms 441 Anxiety Disorders 420 Pain 419 Neoplasm Metastasis 385 Esophageal Neoplasms 384 Polycystic Ovary Syndrome 374 Precursor Cell Lymphoblastic Leukemia-Lymphoma 354 Urinary Bladder Neoplasms 351 Fatigue 340 Melanoma 323 Multiple Myeloma 322 Lymphoma 306 Depression 306 Endometrial Neoplasms 290 Liver Neoplasms 279

Interventions

Minimally Invasive Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Interventional × Laparoscopy × Clear all

NCT03837782 2019-02-12

LRLCC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Enrolling by invitation

Laparoscopy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡